CarePill — Medication Tracker

iOS app by Takumi Sekiguchi. Medical · Takumi Sekiguchi

Store rating
0 / 5
Store rating count
0
Download price
Free to download
In-app purchases
Unknown
Version
1.1.6
Listing last refreshed
2026-09-09

View the original store listing

Store description excerpt

Manage medication schedules and today's dose records for a parent, spouse, or other family member on one iPhone. ONE PROFILE PER PERSON Create a profile for each person, then add medications and schedules. Switch profiles to see each person's plan. TODAY AT A GLANCE See today's scheduled doses and mark each dose taken or skipped with one tap. LOCAL REMINDERS Set daily schedules or choose specific weekdays. CarePill sends local notifications at the times you choose. INCLUDED FOR FREE • Up to 2 patient profiles • Unlimited medications and schedules for those patients • Taken and skipped dose records • Local notifications • One banner ad on the patient list FULL ACCESS — ONE-TIME PURCHASE • Unlimited patient profiles • No ads • No subscription Patient, medication, schedule, and dose data are stored on your device. No CarePill account or cloud sync is required. The advertising SDK may process device and ad-interaction data as described in the Privacy Policy. CarePill is a scheduling aid, not a medical device. It does not provide medical advice, diagnose conditions, or verify drug interactions. Always follow the guidance of a qualified healthcare professional. Privacy Policy: https://smallappworks.com/carepill/privacy/ Support: https://smallappworks.com/carepill/support/ Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

Review coverage

AppRill has captured 0 reviews for this app. This is a collected sample, separate from the store rating count. Latest review capture: Not captured yet.

Recent captured chart positions

No chart positions have been captured for this app yet.

Chart position, rating count and review coverage do not establish downloads, revenue or profit. Understand the differences.